Comprehensive assessment of metabolic syndrome among rural Bangladeshi women

BMC Public Health

Tetsu Watanabe²  Michiaki Hiroe⁴  Yoshio Iwashima³  Naoto Yamaguchi⁵  Sohel Zaedi⁵  Sayeeda Nusrat Sultana¹  MdSohag Mia¹  AMShahidul Islam¹  MdReazul Islam¹  Subrina Jesmin¹ 

[1] Health and Disease Research Center for Rural Peoples, Ena Arista, Flat # B-3, House # 802, Road # 3, Baitul Aman Housing Society, Adabor, Dhaka 1207, Bangladesh;Department of public Health, Tokai University Graduate School of Medicine, Isehara, Japan;Division of Hypertension and Nephrology, National Cardiovascular Center of Japan, 5-7-1, Fujishirodai, Suita City, Osaka, Japan;National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan;Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Ami-machi, Inashiki-gun, Ibaraki 300-0394, Japan

关键词: Women;    Rural populations;    Bangladesh;    Western;    Asia;    Metabolic syndrome X;   

Others  :  1163925
DOI  :  10.1186/1471-2458-12-49

 received in 2011-09-03, accepted in 2012-01-19,  发布年份 2012

【 摘 要 】

Background

Metabolic syndrome (MS), defined as a constellation of cardiovascular disease (CVD) risk factors, is one of the fastest growing public health burdens in the Asia-Pacific region. This trend is despite the fact that people in this region are no more overweight than Europeans and Americans. Unfortunately, in South Asia, MS screening has only been performed in a few countries other than Bangladesh. Therefore the present study is designed to conduct a comprehensive screening of MS in Bangladeshi rural women, which includes estimation of prevalence and assessment of risk factor.

Methods

A total of 1535 rural Bangladesh women aged ≥ 15 years were studied using a population based cross-sectional survey. The prevalence of MS was estimated using NCEP ATP III, modified NCEP ATP III and IDF criteria.

Results

The prevalence rates of MS were 25.60% (NCEP ATP III), 36.68% (modified NCEP ATP III), and 19.80% (IDF), as revealed by the present study. Furthermore, based on the NCEP ATP III criteria, 11.60% of the subjects were found to have excess waist circumference; 29.12% had elevated blood pressure, 30.42% had elevated fasting plasma glucose level, 85.47% had low HDL values and 26.91% had increased triglyceride values. Low plasma HDL level was found to be the most common abnormality in the target population and elevated waist circumference was the least frequent component.

Conclusions

The present study reveals a high prevalence of MS and its associated risk factors in rural Bangladeshi women. These findings are important in that they provide insights that will be helpful in formulating effective public health policy, notably the development of future health prevention strategies in Bangladesh.

【 授权许可】

   
2012 Jesmin et al; BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the MS defined by the IDF and national cholesterol education program: the Norwegian HUNT 2 study. BMC Publ Health 2007, 7:220. BioMed Central Full Text
• [2]Magat C, Goel NK, Walia DK, Agawal N, Sharma MK, Kaur J, Singh R, Singh G: Metabolic syndrome: a challenging health issue in highly urbanized union territory of north India. Diabetol Metab Syndr 2010, 2:19. BioMed Central Full Text
• [3]Eapen D, Kalra GL, Merchant N, Arora A, Khan BV: Metabolic syndrome and cardiovascular disease in south Asians. Vasc Health Risk Manag 2009, 5:731-743.
• [4]Gupta M, Singh N, Verma S: South Asians and cardiovascular risk: what clinicians should know. Circulation 2006, 113:e924-e929.
• [5]Misra A, Misra R, Wijesuriya M, Banerjee D: The metabolic syndrome in South Asians: continuing escalation and possible solutions. Indian J Med Res 2007, 125:345-354.
• [6]Mohan V, Deepa M: The metabolic syndrome in developing countries. Diabetes Voice 2006, 51:15-17.
• [7]Rahim MA, Hussain A, Khan AKA, Sayeed MA, Keramat Ali SM, Vaaler S: Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes Res Clin Pract 2007, 77:300-305.
• [8]Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel: Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
• [9]The IDF Consensus Worldwide Definition of the Metabolic Syndrome, International Diabetes Federation 2005. [updated 2006; cited 2007 November 15]; available from: [http://www.idf.org/webdata/docs/MetS_def_update2006.pdf webcite
• [10]Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
• [11]Yen IH, Syme SL: The social environment and health: a discussion of the epidemiologic literature. Annu Rev Public Health 1999, 20:287-308.
• [12]Argos M, Parvez F, Chen Y, Hussain AZ, Momotaj H, Howe GR, Graziano JH, Ahsan H: Socioeconomic status and risk for arsenic-related skin lesions in Bangladesh. Am J Public Health 2007, 97:825-831.
• [13]Durkin MS, Islam S, Hasan ZM, Zaman SS: Measures of socioeconomic status for child health research: comparative results from Bangladesh and Pakistan. Soc Sci Med 1994, 38:1289-1297.
• [14]Das M, Pal S, Ghosh A: Rural urban differences of cardiovascular disease risk factors in adult Asian Indians. Am J Hum Biol 2008, 20:440-445.
• [15]Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
• [16]Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003, 26:1781-1785.
• [17]Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract 2003, 61:29-37.
• [18]Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003, 163:427-436.
• [19]Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D: Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care 2003, 26:3198-3199.
• [20]Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004, 27:2444-2449.
• [21]Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K: Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004, 97:257-261.
• [22]DECODE Study Group, Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European men and women. Arch Intern Med 2004, 164:1066-1076.
• [23]Ilanne-Parikka P, Eriksson JG, Lindström J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, et al.: Finnish Diabetes Prevention Study Group Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004, 27:2135-2140.
• [24]Jørgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K: Greenland Population Study Prevalence of the metabolic syndrome among the Inuit in Greenland: a comparison between two proposed definitions. Diabet Med 2004, 21:1237-1242.
• [25]Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, Gill T, Ruffin R: Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 2005, 28:2777-2779.
• [26]Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP: The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 2005, 21:1157-1159.
• [27]Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fabregas M: NóvoaFJ: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med 2005, 22:1751-1756.
• [28]Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005, 28:2745-2749.
• [29]Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M: Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res 2005, 28:27-34.
• [30]Lorenzo C, Williams K, Gonzalez-Villalpando C, Haffner SM: The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Diabetes Care 2005, 28:2480-2485.
• [31]Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee, Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH: The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005, 67:251-257.
• [32]He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu FB: Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006, 47:1588-1594.
• [33]Li ZY, Xu GB, Xia TA: Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Atherosclerosis 2006, 184:188-192.
• [34]Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M: Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health 2006, 6:92. BioMed Central Full Text
• [35]Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007, 23:127-134.
• [36]Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N: High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001, 25:1722-1729.
• [37]Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al.: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
• [38]Linsel-Nitschke P, Tall AR: HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov 2005, 4:193-205.
• [39]Von Eckardstein A: Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis 2006, 186:231-239.
• [40]Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F: Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol 2009, 44:136-160.
• [41]Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the middle east. The national survey of risk factors for non communicable disease of Iran. Diabetes Care 2009, 32:1092-1097.
• [42]Holleboom AG, Vergeer M, Hovingh GK, et al.: The value of HDL genetics. Curr Opin Lipidol 2008, 19:385-394.
• [43]Zaman MM, Choudhury SR, Ahmed J, Numan SM, Islam MS, Yoshiike N: Non-biochemical risk factors for cardiovascular disease in general clinic-based rural population of Bangladesh. J Epidemiol 2004, 14:63-68.
• [44]Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS, et al.: Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract 2010, 89:181-188.
• [45]Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R: Intra-urban differences in the prevalence of the metabolic syndrome in southern India--the Chennai Urban Population Study (CUPS No. 4). Diabet Med 2001, 18:280-287.
• [46]Ramachandran A, Snehalatha C, Mohan V, Viswanathan M: Development of carbohydrate intolerance in offspring of Asian Indian conjugal type 2 diabetic parents. Diabetes Res Clin Pract 1990, 8:269-273.
• [47]Srinivasan SR, Frontini MG, Berenson GS: Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes. Metabolism 2003, 52:443-450.
• [48]Anjana RM, Lakshminarayanan S, Deepa M, Farooq S, Pradeepa R, Mohan V: Parental history of type 2 diabetes mellitus, metabolic syndrome and cardiometabolic risk factors in Asian Indian adolescents. Metabolism 2009, 58:344-350.
• [49]Rahim MA, Azad Khan AK, Sayeed MA, Akhtar B, Nahar Q, Ali SMK, Hussain A: Metabolic syndrome in rural Bangladesh: Comparison of newly proposed IDF, modified ATP III and WHO criteria and their agreements. Diabetes Metab Syndr Clin Res Rev 2007, 1:251-257.
• [50]Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008, 93:S9-S30.
• [51]Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, et al.: Heterogeneity of coronary heart risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. Br Med J 1999, 319:215-220.
• [52]Eriksson KF, Lindgärde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 1991, 34:891-898.
• [53]Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537-544.
• [54]Finnish Diabetes Prevention Study Group, Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.